Cyr61 mediates oxaliplatin resistance in colorectal cancer cells by regulating Bcl-xL expression

Although the clinical application of oxaliplatin (L-OHP) has improved the survival of colorectal cancer (CRC) patients, approximately half of patients with CRC fail to achieve good clinical outcomes, indicating resistance to L-OHP therapy. Cysteine-rich protein 61 (Cyr61), a multifunctional extracel...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Cancer
Main Authors: Song, Yanfang, Kang, Yanli, Lin, Zhen, Zeng, Menglu, Shi, Pengchong, Lin, Jia, Lu, Pingxia, Luo, Li, Cao, Yingping, Zhu, Xianjin
格式: Artigo
語言:Inglês
出版: Ivyspring International Publisher 2021
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7974528/
https://ncbi.nlm.nih.gov/pubmed/33753993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.48891
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍